Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
16 Results for "
PTPN1
" in MedChemExpress (MCE) Product Catalog:
Products (16)
16 Results for "PTPN1" in MCE Product Catalog:
7
7 Cited Publications
Synonyms: ABBV-CLS-484
Target:
Research Areas:
Osunprotafib (ABBV-CLS-484) is an orally active and selective active site PTPN1 (IC50: 2.5 nM) and PTPN2(IC50: 1.8 nM) inhibitor. Osunprotafib has 6-8-fold weaker activity on PTPN9 and no detectable activity on SHP-1 or SHP-2. Osunprotafib increases the sensitivity of human cancer cell lines to IFNγ. Osunprotafib generates robust anti-tumor immunity by enhancing JAK-STAT signalling and reducing T cell dysfunction [1] .
1
1 Cited Publications
Cat. No.: HY-P73685
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PTPN1; Protein-Tyrosine Phosphatase 1B; Prev. PTP1B; Protein Tyrosine Phosphatase, Placental; Tyrosine-Protein Phosphatase Non-Receptor Type 1; PTP-1B; Protein Tyrosine Phosphatase Non-Receptor Type 1; Tyrosine-Protein Phosphatase Non-Receptor Type
Species:
Human
Source:
E. coli
Synonyms: PTPN2/1-IN-1
Target:
Research Areas:
Tegeprotafib (PTPN2/1-IN-1) (Compound 124) is an orally active PTPN1 and PTPN2 inhibitor with IC50s of 4.4 nM and 1-10 nM against PTPN2 and PTP1B, respectively [1].
Cat. No.: HY-RS11415
Target:
Research Areas:
PTPN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PTPN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-178716
CAS No.: 3093350-55-8
Target:
Research Areas:
PTPN2/1-IN-4 (Compound WS35) is an orally active, dual-functional inhibitor of PTPN1 and PTPN2 with IC50s of 12.8 and 5.8 nM for PTPN1 and PTPN2, respectively. PTPN2/1-IN-4 modulates the IFNγ-JAK-STAT signaling pathway and significantly augments CD8+ T-cell tumor infiltration. PTPN2/1-IN-4 has potent anticancer activity, robustly inhibiting tumor growth both as a monotherapy and in combination with an anti-PD-1 antibody in B16-OVA syngeneic mouse models [1].
Cat. No.: HY-145923B
CAS No.: 2986745-48-4
Synonyms: ABBV-CLS-484 hydrochloride
Target:
Research Areas:
Osunprotafib (ABBV-CLS-484) hydrochloride is an orally active and selective active site PTPN1 (IC50: 2.5 nM) and PTPN2(IC50: 1.8 nM) inhibitor. Osunprotafib hydrochloride has 6-8-fold weaker activity on PTPN9 and no detectable activity on SHP-1 or SHP-2. Osunprotafib hydrochloride increases the sensitivity of human cancer cell lines to IFNγ. Osunprotafib hydrochloride generates robust anti-tumor immunity by enhancing JAK-STAT signalling and reducing T cell dysfunction [1] .
Cat. No.: HY-RS17205
Target:
Research Areas:
Ptpn1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ptpn1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS23657
Target:
Research Areas:
Ptpn1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ptpn1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P81300AA
Synonyms: PTPN1; PTP1B; Tyrosine-protein phosphatase non-receptor type 1; Protein-tyrosine phosphatase 1B; PTP-1B
Cat. No.: HY-P81300A
Synonyms: PTPN1; PTP1B; Tyrosine-protein phosphatase non-receptor type 1; Protein-tyrosine phosphatase 1B; PTP-1B
Cat. No.: HY-183937A
Target:
Research Areas:
PD-305 is a selective PTPN2 PROTAC degrader, with DC50 values of 0.25 nM and 5.11 nM against PTPN2 and PTPN1, respectively. PD-305 enhances IFN-γ-induced STAT1 phosphorylation, inhibits the proliferation of IFN-γ-stimulated colorectal cancer cells, promotes CD8 + T cell activation, enhances the tumor-killing activity of T cells, and suppresses tumor growth in mouse models. PD-305 can be used for the research of colorectal cancer [1].
Cat. No.: HY-P11604
Target:
Research Areas:
Cat. No.: HY-P71315
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SIRPB2; Protein Tyrosine Phosphatase Non-Receptor Type Substrate Protein; Prev. PTPNS1L3; SIRP-Beta-2; Prev. PTPN1L; Protein Tyrosine Phosphatase Non-Receptor Type Substrate 1-Like 3; DJ776F14.2; Protein Tyrosine Phosphatase, Non-Receptor Type 1-Like; Pro
Species:
Human
Source:
HEK293
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
